title: The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer .
abstract: Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/ Akt signaling pathway in a wide variety of tumors. A series of thieno[3,2-d]pyrimidine derivatives were prepared and evaluated as inhibitors of PI3 kinase p110alpha. The synthesis, biological activity, and further profiling of these compounds are described. This work resulted in the discovery of 17, GDC-0941, which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clinical trials for the treatment of cancer.
authors.affiliation: Piramed Pharma, 957 Buckingham Avenue, Slough, Berks SL1 4NL, United Kingdom. adrian.folkes@piramed.com
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Folkes
authors.forename: Khatereh
authors.initials: K
authors.lastname: Ahmadi
authors.forename: Wendy K
authors.initials: WK
authors.lastname: Alderton
authors.forename: Sonia
authors.initials: S
authors.lastname: Alix
authors.forename: Stewart J
authors.initials: SJ
authors.lastname: Baker
authors.forename: Gary
authors.initials: G
authors.lastname: Box
authors.forename: Irina S
authors.initials: IS
authors.lastname: Chuckowree
authors.forename: Paul A
authors.initials: PA
authors.lastname: Clarke
authors.forename: Paul
authors.initials: P
authors.lastname: Depledge
authors.forename: Suzanne A
authors.initials: SA
authors.lastname: Eccles
authors.forename: Lori S
authors.initials: LS
authors.lastname: Friedman
authors.forename: Angela
authors.initials: A
authors.lastname: Hayes
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Hancox
authors.forename: Arumugam
authors.initials: A
authors.lastname: Kugendradas
authors.forename: Letitia
authors.initials: L
authors.lastname: Lensun
authors.forename: Pauline
authors.initials: P
authors.lastname: Moore
authors.forename: Alan G
authors.initials: AG
authors.lastname: Olivero
authors.forename: Jodie
authors.initials: J
authors.lastname: Pang
authors.forename: Sonal
authors.initials: S
authors.lastname: Patel
authors.forename: Giles H
authors.initials: GH
authors.lastname: Pergl-Wilson
authors.forename: Florence I
authors.initials: FI
authors.lastname: Raynaud
authors.forename: Anthony
authors.initials: A
authors.lastname: Robson
authors.forename: Nahid
authors.initials: N
authors.lastname: Saghir
authors.forename: Laurent
authors.initials: L
authors.lastname: Salphati
authors.forename: Sukhjit
authors.initials: S
authors.lastname: Sohal
authors.forename: Mark H
authors.initials: MH
authors.lastname: Ultsch
authors.forename: Melanie
authors.initials: M
authors.lastname: Valenti
authors.forename: Heidi J A
authors.initials: HJ
authors.lastname: Wallweber
authors.forename: Nan Chi
authors.initials: NC
authors.lastname: Wan
authors.forename: Christian
authors.initials: C
authors.lastname: Wiesmann
authors.forename: Paul
authors.initials: P
authors.lastname: Workman
authors.forename: Alexander
authors.initials: A
authors.lastname: Zhyvoloup
authors.forename: Marketa J
authors.initials: MJ
authors.lastname: Zvelebil
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Shuttleworth